Given to previous reports that GLP plasma concentrations are altered in obesity and MASLD, which are frequently associated with diabetes, we therefore thought to investigate whether baseline GLP-1 or GLP-2 plasma level are associated with these conditions. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.